You would have had to been around for a while - and had a great memory - to recall we mentioned N-Viro International (NVIC) waaaayyyy back in January of last year. At the time this ‘clean coal’ stock was trading right around $3.00. And, it stayed around $3.00 for a long, long time…..months. In fact, it drifted lower - to the $2.50-ish area - late last year.

After taking the year off, NVIC finally got off the couch in January of 2008. By early March it would hit a high of $4.25. So, there is some life still left here, though only for the insanely patient.

Of course, the pullback to last week’s low of $3.00 sort of negates all the gain, so what’s my point?

Take a closer look at the chart. That low of $3.00 was also a retest of, and push off of, the 200 day moving average line. We’re back to $3.70 now, and may be on the rise again. The strong peak and sudden selloff may have just been enough to shake off all the nervous-Nellies, leaving behind the serious traders.

I don’t know whey the sudden renewed interest. Clean coal is one of my mega-trend picks, but with the understanding that it will take a mega-long time for the idea to bear fruit for investors. In the meantime, NVIC may be one of those clean coal investments with a short-term ‘trade’ opportunity.

If anybody has anything to add or offer (about N-Viro or coal in general), please do so below.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Looks like small cap stock pick V2K (VTOK) is off to a good start following yesterday afternoon’s decision to put it on watch. It may be a little frothy today, but if we see a good pullback and rebound attempt, we’ll likely turn the unofficial trade into an official one. In the meantime though, keep your eyes peeled for Thursday afternoon’s (post close) edition. We’ll have another small cap trading idea for you then…a really cool biotech pick.

I don’t want to let the cat too far out of the bag, but this pre-revenue company is on the verge of removing the ‘pre’ from the description. More importantly, they already have a handful of legitimate revenue sources to work with once they’re open for business. The coolest part of all - they’re not in the R&D business (which can be a risky all-or-nothing proposition). They’re actually in the biotech R&D support business. It’s still profitable, but also reliable.

I may be able to drop a couple more hints in the blog between now and then, but you won’t actually get the small cap biotech company’s name until after the market closes on Thursday.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.